Villacrusis, Juvelyn .
HRN: 27-97-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2025
CEFUROXIME 500MG (TAB)
10/21/2025
10/28/2025
PO
500 Mg
BID
S/P NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes